Educational Forum on Medical Device Reporting, Complaint Files, and Recalls, Corrections, and Removals; Public Workshop, 26769-26770 [2012-10893]
Download as PDF
Federal Register / Vol. 77, No. 88 / Monday, May 7, 2012 / Notices
ACTION:
Notice of public workshop.
sroberts on DSK5SPTVN1PROD with NOTICES
The Food and Drug Administration
(FDA) Center for Drug Evaluation and
Research, in cosponsorship with the
International Society for Pharmaceutical
Engineering (ISPE), is planning a
multiday, educational public workshop
entitled ‘‘Redefining the ‘C’ in CGMP:
Creating, Implementing, and Sustaining
a Culture of Compliance.’’
DATES: Date and Time: The public
workshop will be held on June 4, 2012,
9 a.m. to 5 p.m. and June 5, 2012, 8 a.m.
to 5 p.m.
Location: The public workshop will
be held at the Renaissance Baltimore
Harborplace Hotel, 202 E. Pratt St.,
Baltimore, MD 21202, 1–800–535–1201.
Contact Persons: FDA Contact:
Rhonda Hill, Center for Drug Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 51, Rm. 4341, Silver Spring,
MD 20993, 301–796–3267,
rhonda.hill@fda.hhs.gov.
ISPE Contact: Julianne Rill,
Continuing Education Program
Manager, 600 N. Westshore Blvd., Suite
900, Tampa, FL 33609; Web site: https://
www.ispe.org/2012-gmp-conference;
email: jrill@ispe.org. (FDA has verified
the Web site address in this
announcement but we are not
responsible for any subsequent changes
to the Web site in this announcement
after this document publishes in the
Federal Register.)
Accommodations: Attendees are
responsible for their own
accommodations. Please mention ISPE/
FDA Conference to receive the hotel
room rate of $195.00 plus applicable
taxes (available until May 7, 2012, or
until the ISPE room block is filled).
If you need special accommodations
due to a disability, please contact ISPE
(see Contact Persons) at least 7 days in
advance of the meeting.
Registration: The ISPE registration
fees cover the cost of facilities,
materials, and refreshments. Seats are
limited; please submit your registration
as soon as possible. Workshop space
will be filled in order of receipt of
registration. Those accepted for the
workshop will receive confirmation.
Registration will close after the
workshop is filled.
COST OF REGISTRATION
ISPE member ...........................
ISPE nonmember (includes
membership).
Federal Government .................
FDA Planning Committee members and invited speakers.
VerDate Mar<15>2010
18:11 May 04, 2012
$1,695
2,035
750
Fee waived.
Jkt 226001
Please visit ISPE’s Web site to confirm
the prevailing registration fees.
To register, please submit a
registration form with your name,
affiliation, mailing address, telephone,
fax number, and email, along with a
check or money order payable to
‘‘ISPE.’’ To register via the Internet, go
to https://www.ispe.org/2012-gmpconference. The registrar will accept
payment by major credit card (Visa/
MasterCard/AMEX only). For more
information on the meeting registration,
or for questions on the workshop,
contact ISPE (see Contact Persons).
The
workshop helps fulfill the Department
of Health and Human Services’ and
FDA’s important mission to protect the
public health. The workshop will
provide those engaged in FDA-regulated
drug manufacturing operations with
information on a number of topics
concerning FDA requirements and
expectations related to current good
manufacturing practice (CGMP). The
joint public workshop offers the
opportunity for participants to join FDA
representatives and industry experts in
face-to-face dialogues. Each year, FDA
speakers provide updates on current
efforts affecting the development of
global regulatory strategies, while
industry professionals from some of
today’s leading pharmaceutical
companies present case studies on how
they employ strategies to manufacture
high quality drugs in their daily
processes. Through a series of sessions
and meetings, the conference will
provide participants with the
opportunity to hear directly from FDA
experts and representatives of global
regulatory authorities on best practices.
Topics for discussion include the
following: (1) The Business Case For
Change; (2) Quality Risk Management—
When, What, and How; (3) Sustaining
Compliance Consistency Throughout
Your Company and Supplier Network;
(4) IT Strategies—Cloud Computing,
RFID, and Beyond; (5) The Future of
Drug Manufacturing. To help ensure the
quality of FDA regulated products, the
workshop helps to achieve objectives set
forth in section 406 of the FDA
Modernization Act of 1997 (Pub. L. 105–
115), which includes working closely
with stakeholders and maximizing the
availability and clarity of information to
stakeholders and the public. The
workshop also is consistent with the
Small Business Regulatory Enforcement
Fairness Act of 1996 (Pub. L. 104–121),
as outreach activities by Government
Agencies to small businesses.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
26769
Dated: May 1, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012–10894 Filed 5–4–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0001]
Educational Forum on Medical Device
Reporting, Complaint Files, and
Recalls, Corrections, and Removals;
Public Workshop
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of public workshop.
The Food and Drug Administration
(FDA), Office of Regulatory Affairs
(ORA), Southwest Region (SWR), Dallas
District Office (DALDO), in
collaboration with the FDA Medical
Device Industry Coalition (FMDIC), is
announcing a public workshop entitled
‘‘Educational Forum on Medical Device
Reporting, Complaint Files, and Recalls,
Corrections, and Removals.’’ The
purpose of the public workshop is to
provide information about FDA’s
Medical Device Quality Systems
Regulation (QSR) to the regulated
industry, particularly small businesses.
DATES: Date and Time: The public
workshop will be held on June 15, 2012,
from 8 a.m. to 5 p.m.
Location: The public workshop will
be held at the Renaissance Dallas Hotel,
2222 Stemmons Freeway, Dallas, TX
75207. Directions and lodging
information are available at the FMDIC
Web site at https://www.fmdic.org/.
Contact Person: David Arvelo, Food
and Drug Administration, 4040 North
Central Expressway, Suite 900, Dallas,
TX 75204, 214–253–4952, FAX: 214–
253–4970, email
david.arvelo@fda.hhs.gov.
Registration: FMDIC has a $250 early
registration fee. Discounts for full-time
students and government employees
with valid identification are available.
Early registration ends June 1, 2012.
Registration is $300 thereafter. For more
information on fees and/or to register
online, please visit https://
www.fmdic.org/. As an alternative, you
may send registration information
including name, title, firm name,
address, telephone and fax numbers,
and email, along with a check or money
order for the appropriate amount
payable to the FMDIC, to FMDIC
Registrar, 4447 N. Central Expressway,
Suite 110 PMB197, Dallas, TX 75205.
E:\FR\FM\07MYN1.SGM
07MYN1
sroberts on DSK5SPTVN1PROD with NOTICES
26770
Federal Register / Vol. 77, No. 88 / Monday, May 7, 2012 / Notices
Registration on site will be accepted on
a space available basis on the day of the
public workshop beginning at 7:30 a.m.
Please note that due to popularity,
similar past events have reached
maximum capacity well before the day
of the event. The cost of registration at
the site is $300 payable to the FMDIC.
The registration fee will be used to
offset expenses of hosting the event
including continental breakfast, lunch,
refreshments, venue, materials,
audiovisual equipment, and other
logistics associated with this event.
If you need special accommodations
due to a disability, please contact David
Arvelo (see Contact Person) at least 21
days in advance.
SUPPLEMENTARY INFORMATION: The
workshop is being held in response to
the interest in the topics discussed from
small medical device manufacturers in
the Dallas District area. This workshop
helps achieve objectives set forth in
section 406 of the Food and Drug
Administration Modernization Act of
1997 (21 U.S.C. 393), which include
working closely with stakeholders and
maximizing the availability and clarity
of information to stakeholders and the
public. This is also consistent with the
purposes of FDA’s Regional Small
Business Program, which are in part to
respond to industry inquiries, develop
educational materials, sponsor
workshops and conferences to provide
firms, particularly small businesses,
with firsthand working knowledge of
FDA’s requirements and compliance
policies. This workshop is also
consistent with the Small Business
Regulatory Enforcement Fairness Act of
1996 (Pub. L. 104–121), as an outreach
activity by Government agencies to
small businesses.
The goal of the workshop is to present
information that will enable
manufacturers and regulated industry to
better comply with the Medical Device
QSR. The following topics will be
discussed at the workshop: (1) The role
of complaint files, (2) medical device
reporting, (3) medical device recalls,
corrections, and removals, and (4)
Corrective and Preventive Actions as
They Relate to Complaints.
Transcripts: Transcripts of this event
will not be available due to the format
of this workshop. Handouts will be
posted online at https://www.fmdic.org/
or may be requested in writing from
David Arvelo (see Contact Person), after
the public workshop.
Dated: May 1, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012–10893 Filed 5–4–12; 8:45 am]
BILLING CODE 4160–01–P
VerDate Mar<15>2010
18:11 May 04, 2012
Jkt 226001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Presenilin
and Alzheimer’s Disease.
Date: June 4, 2012.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, National
Institute on Aging, Gateway Building 2C/212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–496–9666,
parsadaniana@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Signal
Transduction and AD.
Date: June 20, 2012.
Time: 11:45 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, National
Institute on Aging, Gateway Building 2C/212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–496–9666,
parsadaniana@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel Cognitive
Decline in Aging Monkeys.
Date: June 29, 2012.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, National
Institute on Aging, Gateway Building 2c/212,
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–496–9666,
parsadaniana@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: May 1, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–10965 Filed 5–4–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; Review of RFA AA–12–008.
Date: May 23–24, 2012.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIAAA, National Institutes of
Health, 5635 Fishers Lane, Rockville, MD
20852 (Virtual Meeting).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch
EPRB, NIAAA, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067,
srinivar@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
E:\FR\FM\07MYN1.SGM
07MYN1
Agencies
[Federal Register Volume 77, Number 88 (Monday, May 7, 2012)]
[Notices]
[Pages 26769-26770]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-10893]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0001]
Educational Forum on Medical Device Reporting, Complaint Files,
and Recalls, Corrections, and Removals; Public Workshop
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public workshop.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA), Office of Regulatory
Affairs (ORA), Southwest Region (SWR), Dallas District Office (DALDO),
in collaboration with the FDA Medical Device Industry Coalition
(FMDIC), is announcing a public workshop entitled ``Educational Forum
on Medical Device Reporting, Complaint Files, and Recalls, Corrections,
and Removals.'' The purpose of the public workshop is to provide
information about FDA's Medical Device Quality Systems Regulation (QSR)
to the regulated industry, particularly small businesses.
DATES: Date and Time: The public workshop will be held on June 15,
2012, from 8 a.m. to 5 p.m.
Location: The public workshop will be held at the Renaissance
Dallas Hotel, 2222 Stemmons Freeway, Dallas, TX 75207. Directions and
lodging information are available at the FMDIC Web site at https://www.fmdic.org/.
Contact Person: David Arvelo, Food and Drug Administration, 4040
North Central Expressway, Suite 900, Dallas, TX 75204, 214-253-4952,
FAX: 214-253-4970, email david.arvelo@fda.hhs.gov.
Registration: FMDIC has a $250 early registration fee. Discounts
for full-time students and government employees with valid
identification are available. Early registration ends June 1, 2012.
Registration is $300 thereafter. For more information on fees and/or to
register online, please visit https://www.fmdic.org/. As an alternative,
you may send registration information including name, title, firm name,
address, telephone and fax numbers, and email, along with a check or
money order for the appropriate amount payable to the FMDIC, to FMDIC
Registrar, 4447 N. Central Expressway, Suite 110 PMB197, Dallas, TX
75205.
[[Page 26770]]
Registration on site will be accepted on a space available basis on the
day of the public workshop beginning at 7:30 a.m. Please note that due
to popularity, similar past events have reached maximum capacity well
before the day of the event. The cost of registration at the site is
$300 payable to the FMDIC. The registration fee will be used to offset
expenses of hosting the event including continental breakfast, lunch,
refreshments, venue, materials, audiovisual equipment, and other
logistics associated with this event.
If you need special accommodations due to a disability, please
contact David Arvelo (see Contact Person) at least 21 days in advance.
SUPPLEMENTARY INFORMATION: The workshop is being held in response to
the interest in the topics discussed from small medical device
manufacturers in the Dallas District area. This workshop helps achieve
objectives set forth in section 406 of the Food and Drug Administration
Modernization Act of 1997 (21 U.S.C. 393), which include working
closely with stakeholders and maximizing the availability and clarity
of information to stakeholders and the public. This is also consistent
with the purposes of FDA's Regional Small Business Program, which are
in part to respond to industry inquiries, develop educational
materials, sponsor workshops and conferences to provide firms,
particularly small businesses, with firsthand working knowledge of
FDA's requirements and compliance policies. This workshop is also
consistent with the Small Business Regulatory Enforcement Fairness Act
of 1996 (Pub. L. 104-121), as an outreach activity by Government
agencies to small businesses.
The goal of the workshop is to present information that will enable
manufacturers and regulated industry to better comply with the Medical
Device QSR. The following topics will be discussed at the workshop: (1)
The role of complaint files, (2) medical device reporting, (3) medical
device recalls, corrections, and removals, and (4) Corrective and
Preventive Actions as They Relate to Complaints.
Transcripts: Transcripts of this event will not be available due to
the format of this workshop. Handouts will be posted online at https://www.fmdic.org/ or may be requested in writing from David Arvelo (see
Contact Person), after the public workshop.
Dated: May 1, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-10893 Filed 5-4-12; 8:45 am]
BILLING CODE 4160-01-P